Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF. (Q51116951)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 October 2006

edit

Language	Label	Description	Also known as
English	Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF.	scientific article published on 16 October 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

title

Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

main subject

heart failure

0 references

author

John Cleland

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

author name string

Alison P Coletta

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

Andrew L Clark

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

publication date

16 October 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

published in

European Journal of Heart Failure

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

page(s)

764-766

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

cites work

Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.10.001

retrieved

21 January 2018

First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.10.001

retrieved

21 January 2018

Treating heart failure with cardiac contractility modulation electrical signals

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.10.001

retrieved

21 January 2018

The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.10.001

retrieved

21 January 2018

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.10.001

retrieved

21 January 2018

Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.10.001

retrieved

21 January 2018

Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.10.001

retrieved

21 January 2018

Identifiers

DOI

10.1016/J.EJHEART.2006.10.001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

PubMed publication ID

17049305

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17049305

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/17049305

ResearchGate publication ID

6747042

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51116951&oldid=1694393199"